Search research articles
Contact Us
Filters
Showing results (221-230 of 306) with videos related to
Page
of 31
Sort By:
The Journal of Nutrition
|
November 10, 1998
A low-viscosity soluble-fiber fruit juice supplement fails to lower cholesterol in hypercholesterolemic men and women
M H Davidson, L D Dugan, J Stocki, et al.
Trends in Ecology & Evolution
|
October 17, 2024
Quantifying elemental diversity to study landscape ecosystem function
Anne M McLeod, Shawn Leroux, Chelsea L Little, et al.
Marine Pollution Bulletin
|
October 4, 2024
Inshore coral reef sediment and turf dynamics unaffected by canopy-forming macroalgae
Stella E Fulton, Tehya Hines, Cathie A Page, et al.
Sports Health
|
November 17, 2018
KOOS-JR Demonstrates Psychometric Limitations in Measuring Knee Health in Individuals After ACL Reconstruction
Jennifer L Hunnicutt, Brittany N Hand, Chris M Gregory, et al.
Molecular Pharmaceutics
|
May 21, 2009
Pharmacokinetics and tumor disposition of PEGylated, methotrexate conjugated poly-l-lysine dendrimers
Lisa M Kaminskas, Brian D Kelly, Victoria M McLeod, et al.
Antimicrobial Agents and Chemotherapy
|
November 15, 2017
Frequency and Mechanism of Spontaneous Resistance to Sulbactam Combined with the Novel β-Lactamase Inhibitor ETX2514 in Clinical Isolates of Acinetobacter baumannii
Sarah M McLeod, Adam B Shapiro, Samir H Moussa, et al.
Mayo Clinic Proceedings
|
October 5, 2021
Medical Cannabis State and Federal Regulations: Implications for United States Health Care Entities
Adam I Perlman, Heidi M McLeod, Elizabeth C Ventresca, et al.
Biomacromolecules
|
July 22, 2017
An Evaluation of Optimal PEGylation Strategies for Maximizing the Lymphatic Exposure and Antiviral Activity of Interferon after Subcutaneous Administration
Linda J Chan, Orlagh M Feeney, Nathania J Leong, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 19, 2013
PEGylation of interferon α2 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer metastases
Lisa M Kaminskas, David B Ascher, Victoria M McLeod, et al.
Molecular Pharmaceutics
|
August 16, 2018
Reducing Dendrimer Generation and PEG Chain Length Increases Drug Release and Promotes Anticancer Activity of PEGylated Polylysine Dendrimers Conjugated with Doxorubicin via a Cathepsin-Cleavable Peptide Linker
Dharmini Mehta, Nathania Leong, Victoria M McLeod, et al.
Page
of 31
Search research articles
Search
Showing results (221-230 of 306) with videos related to
Sort By:
Page
of 31
The Journal of Nutrition
|
November 10, 1998
A low-viscosity soluble-fiber fruit juice supplement fails to lower cholesterol in hypercholesterolemic men and women
M H Davidson, L D Dugan, J Stocki, et al.
Trends in Ecology & Evolution
|
October 17, 2024
Quantifying elemental diversity to study landscape ecosystem function
Anne M McLeod, Shawn Leroux, Chelsea L Little, et al.
Marine Pollution Bulletin
|
October 4, 2024
Inshore coral reef sediment and turf dynamics unaffected by canopy-forming macroalgae
Stella E Fulton, Tehya Hines, Cathie A Page, et al.
Sports Health
|
November 17, 2018
KOOS-JR Demonstrates Psychometric Limitations in Measuring Knee Health in Individuals After ACL Reconstruction
Jennifer L Hunnicutt, Brittany N Hand, Chris M Gregory, et al.
Molecular Pharmaceutics
|
May 21, 2009
Pharmacokinetics and tumor disposition of PEGylated, methotrexate conjugated poly-l-lysine dendrimers
Lisa M Kaminskas, Brian D Kelly, Victoria M McLeod, et al.
Antimicrobial Agents and Chemotherapy
|
November 15, 2017
Frequency and Mechanism of Spontaneous Resistance to Sulbactam Combined with the Novel β-Lactamase Inhibitor ETX2514 in Clinical Isolates of Acinetobacter baumannii
Sarah M McLeod, Adam B Shapiro, Samir H Moussa, et al.
Mayo Clinic Proceedings
|
October 5, 2021
Medical Cannabis State and Federal Regulations: Implications for United States Health Care Entities
Adam I Perlman, Heidi M McLeod, Elizabeth C Ventresca, et al.
Biomacromolecules
|
July 22, 2017
An Evaluation of Optimal PEGylation Strategies for Maximizing the Lymphatic Exposure and Antiviral Activity of Interferon after Subcutaneous Administration
Linda J Chan, Orlagh M Feeney, Nathania J Leong, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 19, 2013
PEGylation of interferon α2 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer metastases
Lisa M Kaminskas, David B Ascher, Victoria M McLeod, et al.
Molecular Pharmaceutics
|
August 16, 2018
Reducing Dendrimer Generation and PEG Chain Length Increases Drug Release and Promotes Anticancer Activity of PEGylated Polylysine Dendrimers Conjugated with Doxorubicin via a Cathepsin-Cleavable Peptide Linker
Dharmini Mehta, Nathania Leong, Victoria M McLeod, et al.
Page
of 31